XNCR Xencor Inc
Healthcare · Pharmaceutical Preparations · Market cap: $2.8B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $351.1K |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $100.9K |
| 2023-Q1 | $0 | $968.3K |
| 2023-Q2 | $0 | $877.3K |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $941.8K |
| 2024-Q1 | $1.0K | $2.2M |
| 2024-Q2 | $0 | $111.9K |
| 2024-Q3 | $0 | $965.8K |
| 2024-Q4 | $0 | $3.3M |
| 2025-Q1 | $0 | $513.0K |
| 2025-Q2 | $0 | $213.6K |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $3.0M |
| 2026-Q1 | $0 | $528.1K |
| 2026-Q2 | $0 | $422.1K |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $3.6M |
Bought$1.0K1 buy day
Sold$18.1M81 sell days
Net insider flow-$18.1Mnet selling · 5 years
Latest trade2026-11-11Cornelissen Bart Jan
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-11 | Sell | Cornelissen Bart Jan | CFO | 10,100 | $39.82 | $402.2K | 1 |
| 2026-11-10 | Sell | RANIERI RICHARD J | Director | 81,252 | $39.25 | $3.2M | 2 |
| 2026-06-18 | Sell | Feigal Ellen | Director | 6,843 | $13.06 | $89.4K | 1 |
| 2026-06-15 | Sell | GORMAN KEVIN CHARLES | Director | 7,527 | $12.31 | $92.7K | 1 |
| 2026-06-15 | Sell | GUSTAFSON KURT A | Director | 5,474 | $12.31 | $67.4K | 1 |
| 2026-06-15 | Sell | RANIERI RICHARD J | Director | 5,474 | $12.31 | $67.4K | 1 |
| 2026-06-15 | Sell | Montgomery Alan Bruce | Director | 5,064 | $12.31 | $62.3K | 1 |
| 2026-04-10 | Sell | Cornelissen Bart Jan | CFO | 3,499 | $12.29 | $43.0K | 1 |
| 2026-03-06 | Sell | Dahiyat Bassil I | CEO | 6,606 | $11.02 | $72.8K | 1 |
| 2026-03-06 | Sell | Desjarlais John R | Other C-suite | 2,502 | $11.02 | $27.6K | 1 |
| 2026-03-06 | Sell | Eckert Celia | General counsel | 1,767 | $11.02 | $19.5K | 1 |
| 2026-03-05 | Sell | Dahiyat Bassil I | CEO | 14,870 | $11.25 | $167.3K | 1 |
| 2026-03-05 | Sell | Desjarlais John R | Other C-suite | 4,118 | $11.25 | $46.3K | 1 |
| 2026-03-05 | Sell | Eckert Celia | General counsel | 3,244 | $11.25 | $36.5K | 1 |
| 2026-03-05 | Sell | Cornelissen Bart Jan | CFO | 2,517 | $11.25 | $28.3K | 1 |
| 2026-03-03 | Sell | Dahiyat Bassil I | CEO | 6,758 | $11.90 | $80.4K | 1 |
| 2026-03-03 | Sell | Desjarlais John R | Other C-suite | 2,663 | $11.90 | $31.7K | 1 |
| 2026-03-03 | Sell | Eckert Celia | General counsel | 1,492 | $11.90 | $17.8K | 1 |
| 2025-12-19 | Sell | Dahiyat Bassil I | CEO | 114,377 | $15.71 | $1.8M | 1 |
| 2025-12-19 | Sell | Desjarlais John R | Other C-suite | 73,367 | $15.72 | $1.2M | 1 |
| 2025-06-16 | Sell | GORMAN KEVIN CHARLES | Director | 3,173 | $9.22 | $29.3K | 1 |
| 2025-06-16 | Sell | Feigal Ellen | Director | 2,993 | $9.22 | $27.6K | 1 |
| 2025-06-16 | Sell | GUSTAFSON KURT A | Director | 2,993 | $9.22 | $27.6K | 1 |
| 2025-06-16 | Sell | RANIERI RICHARD J | Director | 2,993 | $9.22 | $27.6K | 1 |
| 2025-06-16 | Sell | Montgomery Alan Bruce | Director | 2,215 | $9.22 | $20.4K | 1 |
| 2025-05-02 | Sell | Valente Nancy | Other C-suite | 4,616 | $11.03 | $50.9K | 1 |
| 2025-04-10 | Sell | Cornelissen Bart Jan | CFO | 3,750 | $8.06 | $30.2K | 1 |
| 2025-03-10 | Sell | Dahiyat Bassil I | CEO | 19,716 | $13.60 | $268.1K | 1 |
| 2025-03-10 | Sell | Desjarlais John R | Other C-suite | 9,697 | $13.60 | $131.9K | 1 |
| 2025-03-10 | Sell | Eckert Celia | General counsel | 5,740 | $13.60 | $78.1K | 1 |
| 2025-03-10 | Sell | Valente Nancy | Other C-suite | 2,565 | $13.60 | $34.9K | 1 |
| 2024-12-04 | Sell | Montgomery Alan Bruce | Director | 1,421 | $27.03 | $38.4K | 1 |
| 2024-12-02 | Sell | Montgomery Alan Bruce | Director | 13,301 | $27.03 | $359.5K | 1 |
| 2024-11-21 | Sell | Dahiyat Bassil I | CEO | 49,278 | $24.07 | $1.2M | 1 |
| 2024-11-13 | Sell | Dahiyat Bassil I | CEO | 3,366 | $24.02 | $80.9K | 1 |
| 2024-11-11 | Sell | Desjarlais John R | Other C-suite | 68,684 | $23.48 | $1.6M | 1 |
| 2024-09-27 | Sell | GORMAN KEVIN CHARLES | Director | 2,654 | $20.68 | $54.9K | 1 |
| 2024-09-27 | Sell | Feigal Ellen | Director | 2,503 | $20.68 | $51.8K | 1 |
| 2024-09-27 | Sell | RANIERI RICHARD J | Director | 2,503 | $20.68 | $51.8K | 1 |
| 2024-09-27 | Sell | ROSA-BJORKESON DAGMAR | Director | 2,503 | $20.68 | $51.8K | 1 |
| 2024-09-27 | Sell | GUSTAFSON KURT A | Director | 2,503 | $20.68 | $51.8K | 1 |
| 2024-09-27 | Sell | Montgomery Alan Bruce | Director | 1,853 | $20.68 | $38.3K | 1 |
| 2024-07-09 | Sell | Desjarlais John R | Other C-suite | 36,329 | $18.32 | $665.5K | 1 |
| 2024-05-02 | Sell | Valente Nancy | Other C-suite | 4,745 | $23.58 | $111.9K | 1 |
| 2024-03-11 | Sell | Dahiyat Bassil I | CEO | 2,741 | $23.50 | $64.4K | 1 |
| 2024-03-11 | Sell | Desjarlais John R | Other C-suite | 1,280 | $23.50 | $30.1K | 1 |
| 2024-03-11 | Sell | Eckert Celia | General counsel | 850 | $23.50 | $20.0K | 1 |
| 2024-03-11 | Sell | Kuch John J | CFO | 849 | $23.50 | $20.0K | 1 |
| 2024-03-06 | Sell | GUSTAFSON KURT A | Director | 14,000 | $23.18 | $324.5K | 1 |
| 2024-03-05 | Sell | Dahiyat Bassil I | CEO | 12,528 | $23.43 | $293.5K | 1 |
| 2024-03-05 | Sell | Desjarlais John R | Other C-suite | 6,629 | $23.43 | $155.3K | 1 |
| 2024-03-05 | Sell | Kuch John J | CFO | 4,474 | $23.43 | $104.8K | 1 |
| 2024-03-05 | Sell | Eckert Celia | General counsel | 3,892 | $23.43 | $91.2K | 1 |
| 2024-02-13 | Sell | Desjarlais John R | Other C-suite | 54,108 | $19.38 | $1.0M | 1 |
| 2024-02-13 | Buy | GORMAN KEVIN CHARLES | Director | 53 | $19.12 | $1.0K | 1 |
| 2023-12-29 | Sell | Dahiyat Bassil I | CEO | 45,000 | $20.93 | $941.8K | 1 |
| 2023-06-21 | Sell | Dahiyat Bassil I | CEO | 33,497 | $26.19 | $877.3K | 1 |
| 2023-03-09 | Sell | Dahiyat Bassil I | CEO | 2,602 | $29.88 | $77.7K | 1 |
| 2023-03-09 | Sell | Desjarlais John R | Other C-suite | 1,230 | $29.88 | $36.8K | 1 |
| 2023-03-09 | Sell | Yang Allen | Other C-suite | 1,094 | $29.88 | $32.7K | 1 |
| 2023-03-09 | Sell | Eckert Celia | General counsel | 711 | $29.88 | $21.2K | 1 |
| 2023-03-09 | Sell | Kuch John J | CFO | 711 | $29.88 | $21.2K | 1 |
| 2023-03-06 | Sell | Dahiyat Bassil I | CEO | 5,831 | $31.42 | $183.2K | 1 |
| 2023-03-06 | Sell | Desjarlais John R | Other C-suite | 4,195 | $31.42 | $131.8K | 1 |
| 2023-03-06 | Sell | Yang Allen | Other C-suite | 4,069 | $31.42 | $127.8K | 1 |
| 2023-03-06 | Sell | Kuch John J | CFO | 2,774 | $31.42 | $87.2K | 1 |
| 2023-03-06 | Sell | Eckert Celia | General counsel | 2,462 | $31.42 | $77.4K | 1 |
| 2023-03-03 | Sell | Dahiyat Bassil I | CEO | 2,851 | $31.54 | $89.9K | 1 |
| 2023-03-03 | Sell | Desjarlais John R | Other C-suite | 1,232 | $31.54 | $38.9K | 1 |
| 2023-03-03 | Sell | Kuch John J | CFO | 919 | $31.54 | $29.0K | 1 |
| 2023-03-03 | Sell | Eckert Celia | General counsel | 427 | $31.54 | $13.5K | 1 |
| 2022-12-19 | Sell | Yang Allen | Other C-suite | 3,737 | $27.00 | $100.9K | 1 |
| 2022-03-09 | Sell | Dahiyat Bassil I | CEO | 2,494 | $29.00 | $72.3K | 1 |
| 2022-03-09 | Sell | Yang Allen | Other C-suite | 1,200 | $28.94 | $34.7K | 1 |
| 2022-03-09 | Sell | Desjarlais John R | Other C-suite | 1,172 | $29.13 | $34.1K | 1 |
| 2022-03-09 | Sell | Eckert Celia | General counsel | 789 | $28.91 | $22.8K | 1 |
| 2022-03-09 | Sell | Kuch John J | CFO | 690 | $28.93 | $20.0K | 1 |
| 2022-03-03 | Sell | Dahiyat Bassil I | CEO | 2,929 | $29.90 | $87.6K | 1 |
| 2022-03-03 | Sell | Desjarlais John R | Other C-suite | 1,240 | $29.86 | $37.0K | 1 |
| 2022-03-03 | Sell | Kuch John J | CFO | 971 | $29.86 | $29.0K | 1 |
| 2022-03-03 | Sell | Eckert Celia | General counsel | 451 | $29.91 | $13.5K | 1 |
| 2021-12-17 | Sell | Yang Allen | Other C-suite | 3,664 | $36.62 | $134.2K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Dahiyat Bassil I | CEO | $0 | $6.3M | 2026-03-06 |
| Desjarlais John R | Other C-suite | $0 | $5.2M | 2026-03-06 |
| RANIERI RICHARD J | Director | $0 | $3.3M | 2026-11-10 |
| Montgomery Alan Bruce | Director | $0 | $519.0K | 2026-06-15 |
| Cornelissen Bart Jan | CFO | $0 | $503.7K | 2026-11-11 |
| GUSTAFSON KURT A | Director | $0 | $471.3K | 2026-06-15 |
| Yang Allen | Other C-suite | $0 | $430.3K | 2023-03-09 |
| Eckert Celia | General counsel | $0 | $411.3K | 2026-03-06 |
| Kuch John J | CFO | $0 | $311.1K | 2024-03-11 |
| Valente Nancy | Other C-suite | $0 | $197.7K | 2025-05-02 |
| GORMAN KEVIN CHARLES | Director | $1.0K | $176.8K | 2026-06-15 |
| Feigal Ellen | Director | $0 | $168.7K | 2026-06-18 |
| ROSA-BJORKESON DAGMAR | Director | $0 | $51.8K | 2024-09-27 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.